Birch, Stewart, Kolasch & Birch, LLP
Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
The present invention relates to new compounds of formula I,to pharmaceutical formulations containing the compounds, and to the use of the compounds in the prevention and/or treatment of mGluR5 receptor-mediated disorders.
AstraZeneca AB
A A A A C A A A A A A A A A A C A C A A A A A A A A C
A61P A61P A61P A61P C07D A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P C07D A61P C07D A61P A61P A61P A61P A61P A61P A61P A61P C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Jalaj Alexander Martin David Louise Tau Abdelmalik Karin Thomas Johan Annika Tomislav Methvin Donald
Arora Mindis Johansson Wensbo Edwards Xin Slassi Staaf Stormann Malmberg Kers Stefanac Isaac McLeod